Glucarpidase -- a carboxypeptidase enzyme that helps break down and remove methotrexate from the body -- was approved by the FDA in 2012 to treat patients with toxic levels of methotrexate in their ...

Oral glucose-lowering medications weren't up to snuff with insulin for gestational diabetes, a randomized clinical trial ...

Long-term Tecfidera use was found to significantly reduce relapse rates and slow disability progression for MS patients in a ...

In the world of drug development, the timing and design of clinical trials can be crucial in getting a new drug to market ...

A patient-led study examines the potential of extended Paxlovid courses for Long COVID relief, documenting varied outcomes ...

Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Health Canada-licensed manufacturer of psychedelic pharmaceuticals specializing in natural psilocybin and MDMA, ...

Drs. Flynn, Park, Kovatsis and Jena are physicians and researchers at Harvard Medical School. Dr. Jena is an author of ...

Patients with generalized myasthenia gravis experienced durable improvements across measures of efficacy and regardless of the time since they were diagnosed.

The study highlights a powerful relationship between regular physical activity and a lower risk of chronic diseases.

With holiday gatherings and New Year's celebrations in the rearview mirror, many Americans are coming down with respiratory ...

Are you a couch potato? Learn how physical inactivity can lead to chronic conditions like obesity, depression, and ...